CORCEPT THERAPEUTICS INC — Director's Dealing 2012

Apr 2, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2012-03-29

Reporting Person: Longitude Venture Partners L.P. (Director, 10% Owner)
Reporting Person: Longitude Capital Associates, L.P. (10% Owner)
Reporting Person: Longitude Capital Partners, LLC (10% Owner)
Reporting Person: Tammenoms Bakker Juliet (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-29	Common Stock	X	856644	$2.96	Acquired	13433573	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-03-29	Warrants (Right to Buy)	$2.96	X	856644	Disposed	2013-04-21	Common Stock (856644)	Direct
2012-03-29	Warrants (Right to Buy)	$4.05	P	856644	Acquired	2014-03-24	Common Stock (856644)	Direct

Footnotes

F1: Warrants exercised pursuant to a Warrant Purchase Agreement dated [March 29, 2012] (the "WPA"). Longitude Venture Partners, L.P. ("LVP") exercised 839,811 of the warrants described herein and Longitude Capital Associates, L.P. ("LCA") exercised 16,833 of the warrants described herein.

F2: This report is filed jointly by Longitude Capital Partners, LLC ("Longitude Capital"), LVP, LCA and Juliet Tammenoms Bakker, all of whom share beneficial ownership of more than 10% of the capital stock of the Issuer. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. LVP is the record holder of 839,811 shares of common stock and LCA is the record holder of 16,833 shares of common stock. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors. Each of Longitude Capital and Ms. Tammenoms Bakker disclaims beneficial ownership of all securities except to the extent of their respective pecuniary interest therein.

F3: Warrants purchased pursuant to the WPA.

F4: LVP is the record holder of 839,811 of the warrants described herein and LCA is the record holder of 16,833 of the warrants described herein. Does not include warrants to purchase 2,261,418 shares of Common Stock beneficially owned by the reporting person and Longitude Capital, LVP, LCA and Juliet Tammenoms Bakker, in the aggregate. Such warrants have an exercise price equal to $2.77 per share and expire on March 24, 2015.